Improving Hyponatremia Outcomes in the Hospital Setting

This on-demand webcast was originally presented live on November 6, 2010 in Philadelphia, Pennsylvania as part of the Pharmacy Learning Network Conference Series.

Sponsored by North American Center for Continuing Medical Education, LLC

Chair

Mark A. Munger, PharmD, FCCP, FACC
Professor
Pharmacotherapy and Internal Medicine
The University of Utah College of Pharmacy
Salt Lake City, Utah

Presenter

Michael J. Cawley, PharmD, RRT, CPFT
Associate Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, Pennsylvania

Intended Learners

This activity is designed for health-system pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

• Identify signs and symptoms of hyponatremia in at-risk patients
• Discuss the role of current and emerging pharmacotherapies according to available safety and efficacy data
• Put into practice prompt diagnosis and management of hyponatremia to reduce morbidity, mortality, and hospital length of stays

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 5-question online post-test with a score of 80% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: December 22, 2010

Expiration Date: December 22, 2011

Estimated time to complete: 0.5 hour

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) of continuing pharmacy education UAN 276-000-10-018-H01-P.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact Kristen Jassin, Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at kjassin@naccme.com. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation Services, NACCME, may be made for a second level of review.

This educational activity is a knowledge-based activity.

Independent Clinical Reviewer: Marc LaPointe, PharmD, BCPS, BCNSP, Associate Professor, College of Medicine, Department of Neurological Surgery, Department of Pharmacy and Clinical Services, Medical University of South Carolina, Charleston, South Carolina

Planning Committee

The planning committee comprises Michael J. Cawley, PharmD, RRT, CPFT, Marc LaPointe, PharmD, BCPS, BCNSP, Mark A. Munger, PharmD, FCCP, FACC, and Kristin Dickie, Mary Johnson, Rich Keenan, Nick Lombardi, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Cawley: Consultant—Biogen Idec, Cardiokine, Inc; Promotional speakers bureau—Cubist

Dr. LaPointe: Promotional speaker bureau—Astellas Pharma US Inc, Boehringer Ingelheim, The Medicines Company

Dr. Munger: disclosed no relevant financial relationships with any commercial interests.

Ms. Dickie, Ms. Johnson, Mr. Keenan, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc, Vertex Pharmaceuticals, Inc, ViroPharma, Inc NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Otsuka America Pharmaceutical, Inc.